The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1483
ISSUE1483
December 7, 2015
Corrections: Eloctate for Hemophilia A & Sumatriptan Patch (Zecuity) for Migraine
Download PDF: US English
Med Lett Drugs Ther. 2015 Dec 7;57(1483):168
Disclosures
Objective(s)
Eloctate for Hemophilia A (Med Lett Drugs Ther 2015; 57:143)
In the table on page 144, the indications and half-life listed for Nuwiq were erroneously taken from the European package insert. The table has been revised online to reflect the US prescribing information. The cost for Nuwiq has also been updated.
A Sumatriptan Patch (Zecuity) for Migraine (Med Lett Drugs Ther 2015; 57:151)
In the introduction on page 151, the triptans were referred to as serotonin (5-HT) receptor antagonists; they are 5-HT1B/1D-receptor agonists.
© The Medical Letter, Inc. All Rights Reserved.
The Medical Letter, Inc. does not warrant that all the material in this publication is accurate and
complete in every respect. The Medical Letter, Inc. and its editors shall not be held responsible for any
damage resulting from any error, inaccuracy, or omission.
This article has been freely provided.
Previous article